Iproniazid Uses, Dosage, Side Effects and more
Withdrawn from the Canadian market in July 1964 due to interactions with food products containing tyrosine.
Iproniazid is a monoamine oxidase inhibitor (MAOI) that was developed as the first anti-depressant.
| Trade Name | Iproniazid |
| Generic | Iproniazid |
| Iproniazid Other Names | Iproniazid, Iproniazida, Iproniazide, Iproniazidum |
| Type | |
| Formula | C9H13N3O |
| Weight | Average: 179.219 Monoisotopic: 179.105862053 |
| Groups | Withdrawn |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
Uses
For the treatment of depression (originally intended to treat tuberculosis).
